Home Search Help Now Email to a Friend
About Us Team McGraw Hits for Tug's Team Grants News/Events Get Involved Resources Give Today Online Store
 
Newsroom
Foundation News
Brain Tumor News
Press Releases
Events
Media Gallery

 

Brain Tumor News : 2007

2008 | 2007 | 2006

JANUARY-MARCH | APRIL-JUNE | JULY-AUGUST | SEPTEMBER-DECEMBER


December 6, 2007 – Symptom Clusters in Patients with Newly Diagnosed Brain Tumors

Current research has looked to identify common symptom clusters among cancer patients. A symptom cluster can be thought of as three or more symptoms that occur at the same time. This study, conducted by Gleason et al., looked at symptom clusters in newly diagnosed brain tumor patients enrolled in a clinical trial of d-threo-methyphenidate (d-MPH). Two symptom clusters were identified using exploratory factor analysis.

Read the complete article.


November 14, 2007 – Stress and Long-Term Survivors of Brain Cancer

A recent study conducted at the Tug McGraw Research Center at Duke documents that long-term survivors of brain cancer – (those surviving 18 months or more) – are just as likely to report themselves as stressed as other patients with brain tumors.

Read the complete article.


October 15, 2007 – Cell Phone Use and Brain Tumors: Urban Myth or Reality?

Everybody seems to be talking on a cell phone today, from your great-grandmother to grade-school kids.  As a result, there has been much debate about whether the use of cell phones (low-energy radiation) causes brain tumors.  This study examines the potential effects of cellular phone use on the risk of brain tumor development.

Read the complete article.


October 15, 2007 – Characteristics of Brain Tumor-Associated Headache

Some people get headaches frequently; others rarely experience one.  While headaches can be painful, most of the time they are soon gone – and we forget all about them.  However, headaches are among the most common symptoms of brain tumors.

Read the complete article.


October 10, 2007 – First Brain Cancer Vaccine Approved in Switzerland

Northwest Biotherapeutics, a US-based company, has announced that it has won approval for commercial use of the world’s first vaccine against brain cancer in Switzerland.  The Tug McGraw Foundation will continue to follow what promise to be “some of the most watched and anticipated clinical trials ever conducted.”

Read the complete article.

All content ©2008 Tug McGraw Foundation. All rights reserved. Contact Us